Latest News
Snapchat Study Aims to Capture Healthcare Ad Dollars Amid Rival Pressure
Snap Inc. published a study indicating 59% of surveyed Snapchat users altered real-world health actions after seeing content on the platform. The move targets healthcare advertising as the company faces pressure from activist investor Irenic Capital.
Soleno Halts European Drug Review Following $2.9B Neurocrine Acquisition
Soleno Therapeutics has withdrawn its European marketing application for VIOKAT, a day after agreeing to a $2.9 billion all-cash acquisition by Neurocrine Biosciences. The move halts a regulatory review previously expected to conclude by mid-2026.
Indian Equities Climb on IT Rally Ahead of RBI Policy, Earnings
Indian benchmarks advanced Tuesday, with the Nifty 50 closing above 23,100, driven by a rally in IT stocks ahead of quarterly earnings and the RBI's policy decision.
Plug Power Surges on Major Quebec Hydrogen Deal Ahead of Investor Tour
Plug Power shares rallied sharply following a significant electrolyzer contract award in Quebec. Company leadership is commencing a Canadian investor roadshow to discuss financial progress and growth strategy.
Nvidia's Slurm Acquisition Sparks AI Ecosystem Control Concerns
Nvidia's acquisition of SchedMD, the developer behind the Slurm workload manager, has ignited concerns about potential hardware favoritism in AI and supercomputing. The chip giant asserts it will maintain Slurm's open-source, vendor-neutral status.
Enovix Surges 12% Amid Analyst Shifts; Indian Markets Slump on Oil Spike
Enovix shares rallied nearly 12% on Monday despite below-average volume and divergent analyst views. Meanwhile, Indian equity indices tumbled over 800 points as Brent crude surged past $111, stoking inflation fears.
Neurocrine Acquires Soleno in $2.9B Deal for Rare Disease Drug Vykat XR
Neurocrine Biosciences will purchase Soleno Therapeutics in a $2.9 billion all-cash transaction, securing the commercial rights to Vykat XR. The deal offers $53 per share to Soleno stockholders.
Hologic CEO to Depart as $18.3B Private Equity Acquisition Nears Completion
Hologic announced CEO Steve MacMillan will step down once the company's $18.3 billion acquisition by Blackstone and TPG finalizes, expected around April 7. The deal will take the women's health technology firm private.
CenterPoint Energy Sees Divergent Institutional Moves Ahead of Q1 Report
Institutional investors showed mixed sentiment toward CenterPoint Energy in Q4, with Aberdeen and Stratos cutting positions while Allspring added shares. The utility reports first-quarter results on April 23.
Oklo Insider Sales Clarified at $11M, Not $21M, Amid Revenue-Less 2025
Regulatory filings show Oklo co-founders and the CFO sold approximately $10.9 million in shares, correcting earlier reports of $21 million in sales. The company reported no revenue and a significant net loss for 2025.